Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study (Q40316484)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2015
edit
Language Label Description Also known as
English
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
scientific article published on June 2015

    Statements

    Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study (English)
    Nandini Raghavan
    Michael T Ropacki
    Ralph N Martins
    Christopher C Rowe
    S Lance Macaulay
    Vaibhav A Narayan
    AIBL Research Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit